Future directions in the treatment of hormone-sensitive advanced breast cancer: the RAD001 (Everolimus)-letrozole clinical program. [electronic resource]
Producer: 20060706Description: S18-25 p. digitalISSN:- 0093-7754
- Aromatase Inhibitors -- therapeutic use
- Breast Neoplasms -- drug therapy
- Clinical Trials as Topic
- Everolimus
- Female
- Forecasting
- Humans
- Immunosuppressive Agents -- therapeutic use
- Letrozole
- Neoplasms, Hormone-Dependent -- drug therapy
- Nitriles -- therapeutic use
- Receptors, Estrogen -- metabolism
- Sirolimus -- analogs & derivatives
- Triazoles -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.